NASDAQ NMS - GLOBAL MARKET · CDIO
+3.63% · +$0.0631 · Vol 25.4K
Market closed · last close 4:00 PM ET · price as of 17:40:20 ET
Cardio Diagnostics Holdings Inc

Cardio Diagnostics Holdings Inc

Biotechnology
$1.80
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
CDIO
Cardio Diagnostics Holdings Inc
Wed Aug 5 · last completed session · Markets closed · resumes Thu 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

77/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Wed Aug 5 · last completed session · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CDIO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CDIO catalysts
About Cardio Diagnostics Holdings Inc
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Listed since
2022
Employees
17
Country
US

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.73
Day high
$1.79
Day low
$1.73
Previous close
$1.74
52W high
$6.55
-72.47% from high
52W low
$1.05
14% of range
Market cap
$5.1M
EPS
$-3.5500
Beta
1.84
Shares out
3M
Volume
25.4K
0.36× rel vol
Avg volume
70.4K
VWAP
$1.75
Price history computed in-house
1W
+14.85%
1M
-5.60%
3M
-1.47%
1Y
-54.24%
YTD
-33.46%
SMA 50 $1.87 · below
SMA 200 $2.50 · below
52W position 14%

CDIO overview

Veridion Score
77
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CDIO.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CDIO Form 4 filings
Public disclosures

Congress activity in CDIO

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CDIO in the cached public ledger.

Federal contracts

CDIO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CDIO in this window.
Lobbying spend

CDIO lobbying filings, year to date.

Registered lobbying filings matched to Cardio Diagnostics Holdings Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CDIO in this window.
Loading news for CDIO
Analyst ratings
Sovereign unlock shows live analyst consensus for CDIO.
Options
Sovereign unlock shows live options positioning for CDIO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.